Literature DB >> 20153509

Clinicopathologic study of 53 metaplastic breast carcinomas: their elements and prognostic implications.

Rin Yamaguchi1, Rie Horii, Ichiro Maeda, Sachie Suga, Masujiro Makita, Takuji Iwase, Masahiko Oguchi, Yoshinori Ito, Futoshi Akiyama.   

Abstract

Metaplastic carcinoma of the breast is a relatively rare cancer and includes various histologic types. In this cancer, metaplastic elements are heterogeneous and sometimes mixed. We investigated, by histopathologic means, these elements and clinical implications that could indicate the clinical course (including the prognosis). Fifty-three metaplastic breast carcinoma cases and their prognoses were investigated by initially examining the presence or absence of spindle-cell elements, and then the presence or absence of other elements. Spindle cells were classified as high or low grade. The number of spindle-cell-positive cases was 24 (45%) of 53. The 24 spindle-cell (+) cases were subdivided into 12 high-grade (HGsp) (distant metastatic rate per 100 person-years, 13.27) and 12 low-grade (LGsp) (0.00) patients. Spindle-cell (-) cases were subdivided into 22 pure squamous cell carcinomas (5.93) and 7 matrix-producing carcinomas (0.00). There were significant differences among the 4 groups with regard to the disease-free period (P = .0081, log-rank test). The distant metastatic risks in the HGsp and pure squamous cell carcinomas groups were significantly higher than that in the matrix-producing carcinoma + LGsp group (nonmetastatic groups) after controlling for the effects of tumor size and lymph node metastasis (P = .019 and P = .016, respectively, Poisson regression model). The presence of high-grade spindle cells was related to the prognosis, and some histologic subtypes may be important with respect to the prognosis. The presence of high-grade spindle cells in metaplastic breast carcinoma may indicate aggressive behavior. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20153509     DOI: 10.1016/j.humpath.2009.10.009

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  21 in total

1.  An unusual breast lump: osseous metaplasia.

Authors:  Meera Joshi; Dionysios D Remoundos; Farid Ahmed; Giles Cunnick; Gabrielle Rees
Journal:  BMJ Case Rep       Date:  2013-02-04

2.  Immunohistochemical study of metaplastic carcinoma and central acellular carcinoma of the breast: central acellular carcinoma is related to metaplastic carcinoma.

Authors:  Rin Yamaguchi; Maki Tanaka; Keiko Kondo; Toshiro Yokoyama; Ichiro Maeda; Shin-Ichi Tsuchiya; Miki Yamaguchi; Ryuji Takahashi; Yutaka Ogata; Hideyuki Abe; Jun Akiba; Osamu Nakashima; Masayoshi Kage; Hirohisa Yano
Journal:  Med Mol Morphol       Date:  2012-03-20       Impact factor: 2.309

3.  Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer.

Authors:  Roberto A Leon-Ferre; Mei-Yin Polley; Heshan Liu; Judith A Gilbert; Victoria Cafourek; David W Hillman; Ahmed Elkhanany; Margaret Akinhanmi; Jenna Lilyquist; Abigail Thomas; Vivian Negron; Judy C Boughey; Minetta C Liu; James N Ingle; Krishna R Kalari; Fergus J Couch; Daniel W Visscher; Matthew P Goetz
Journal:  Breast Cancer Res Treat       Date:  2017-09-14       Impact factor: 4.872

4.  "High-grade" central acellular carcinoma and matrix-producing carcinoma of the breast: correlation between ultrasonographic findings and pathological features.

Authors:  Rin Yamaguchi; Maki Tanaka; Yasuko Mizushima; Yoshitake Hirai; Miki Yamaguchi; Hiroshi Terasaki; Toshiro Yokoyama; Shin-ichi Tsuchiya; Osamu Nakashima; Hirohisa Yano
Journal:  Med Mol Morphol       Date:  2011-09-16       Impact factor: 2.309

5.  Matrix-Producing Carcinoma of the Breast: Case Report.

Authors:  Canan Kelten; Ceren Boyacı; Cem Leblebici; Didem Can Trabulus; Umar Rıza Gürsu; Mehmet Ali Nazlı; Erol Rüştü Bozkurt
Journal:  J Breast Health       Date:  2015-10-01

6.  Novel model for basaloid triple-negative breast cancer: behavior in vivo and response to therapy.

Authors:  Lisa D Volk-Draper; Sandeep Rajput; Kelly L Hall; Andrew Wilber; Sophia Ran
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

Review 7.  A Comparative Review of Mixed Mammary Tumors in Mammals.

Authors:  Eman S A Saad; Jacqueline S Y Lam; Awf A Al-Khan; Mourad Tayebi; Michael J Day; Samantha J Richardson; Janine A Danks
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-11-28       Impact factor: 2.673

8.  Metaplastic carcinoma of the breast: Clinicopathological features and treatment outcomes with long-term follow up.

Authors:  Aron Gortman; Noel J Aherne; Justin Westhuyzen; Julan V Amalaseelan; Patrick M Dwyer; Matthew Hoffmann; Andrew T Last; Thomas P Shakespeare
Journal:  Mol Clin Oncol       Date:  2021-07-01

9.  Subcellular localization of EZH2 phosphorylated at T367 stratifies metaplastic breast carcinoma subtypes.

Authors:  Emily R McMullen; Stephanie L Skala; Maria E Gonzalez; Sabra Djomehri; Darshan Shimoga Chandrashekar; Sooryanarayana Varambally; Celina G Kleer
Journal:  Breast Cancer       Date:  2020-11-27       Impact factor: 4.239

10.  Metaplastic carcinomas of the breast without evidence of epithelial differentiation: a diagnostic approach for management.

Authors:  Emad A Rakha; Cecily M Quinn; Maria Pia Foschini; Monica Muñoz Martin; David J Dabbs; Sunil Lakhani; Zsuzsanna Varga; Sarah E Pinder; Fernando C Schmitt; Jorge S Reis-Filho; Stephen B Fox; Ian O Ellis; Puay-Hoon Tan; Raluca Mihai
Journal:  Histopathology       Date:  2020-12-16       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.